46G-24136-40587

3 vaccinations 18 coded responses 36 check-ins 18 free-text entries 5 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 494 / MI
Registered: 2020-12-29

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-29
Registered in v-safe
2020-12-29
Dose 1 — Pfizer-BioNTech
2020-12-29
Survey response — day 0, dose 1
MedDRA: Dizziness, Palpitations — Feeling: Fair · Fever · Chills, Fatigue or tiredness

Free text: Light headedness, mild palpitations

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-30
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Palpitations — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work

Free text: Light-headedness, palpitations

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-30
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-31
Survey response — days 1–6 daily, dose 1
MedDRA: Livedo reticularis, Neuropathy peripheral — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work

Free text: Mottling neuropathy of the hands

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-31
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2021-01-01
Survey response — days 1–6 daily, dose 1
MedDRA: Neuropathy peripheral — Feeling: Fair · Joint pains, Muscle or body aches, Nausea, Diarrhea, Abdominal pain

Free text: Mild neuropathy of hands 1-2hrs

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-02
Survey response — days 1–6 daily, dose 1
MedDRA: Neuropathy peripheral — Feeling: Fair · Joint pains, Nausea, Abdominal pain

Free text: Mild,neuropathy 1-2 hrs, hands

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Diarrhea, Abdominal pain

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Nausea, Diarrhea

Adult check-in
2021-01-06
Health check-in — day 7, dose 1
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-12
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-01-19
Dose 2 — Pfizer-BioNTech
2021-01-19
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-19
Survey response — day 0, dose 2
MedDRA: Dizziness, Neuropathy peripheral — Feeling: Fair · Headache

Free text: 1-Neuropathy in the left face and lips, 2- light-headedness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-21
Survey response — days 1–6 daily, dose 2
MedDRA: Neuropathy peripheral — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Neuropathy in the hands, moderate

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-22
Survey response — days 1–6 daily, dose 2
MedDRA: Neuropathy peripheral — Feeling: Fair · Headache, Joint pains

Free text: Neuropathy, fingers, mild

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-23
Survey response — days 1–6 daily, dose 2
MedDRA: Neuropathy peripheral — Feeling: Fair · Joint pains, Fatigue or tiredness

Free text: Mild neuropathy, hands

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-24
Survey response — days 1–6 daily, dose 2
MedDRA: Adverse reaction — Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Free text: Moderate neuropathy, hands

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-25
Survey response — days 1–6 daily, dose 2
MedDRA: Neuropathy peripheral — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Nausea

Free text: Neuropathy, hands mild.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Survey response — day 7, dose 2
MedDRA: Neuropathy peripheral — Feeling: Fair · Joint pains, Fatigue or tiredness

Free text: Mild neuropathy, hands

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-02
Survey response — day 14, dose 2
MedDRA: Arthralgia, Fatigue, Migraine, Pre-existing disease — Feeling: Fair

Free text: Worsening of chronic fatigue. Recurrent migraine headache. Worsened joint pain.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Survey response — day 21, dose 2
MedDRA: Neuropathy peripheral — Feeling: Fair

Free text: Persistent neuropathy across hands/feet and left side of face.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Survey response — day 28, dose 2
MedDRA: Ageusia, Anosmia, Oropharyngeal pain — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Sore throat with exudate. Complete oss of taste and smell

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Report sent to call center — day 28, dose 2
Be unable to work · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-23
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-03-02
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-04-20
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-07-22
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-07-28
Call 1 — Left Voicemail
2021-09-29
Dose 3 — Pfizer-BioNTech
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Joint pains, Fatigue or tiredness, Nausea

Adult check-in
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-10-06
Health check-in — day 7, dose 3
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-10-14
Survey response — day 14, dose 3
MedDRA: Arthritis, Pre-existing disease — Feeling: Fair

Free text: Inflammatory arthritis flare

MedDRA releases: 2024-11 · check-in free text available
2021-10-22
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2021-10-27
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-11-03
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2021-11-10
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-12-29
Survey response — 3 months, dose 3
MedDRA: Headache — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Intractable headache X1 week

MedDRA releases: 2024-11 · check-in free text available
2021-12-29
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-30
Call 1 — Left Voicemail
2022-03-31
Survey response — 6 months, dose 3
MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Chronic Daily migraine persistent since on 12/28/21

MedDRA releases: 2024-11 · check-in free text available
2022-03-31
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-04
Call 1 — Left Voicemail
2022-10-01
Health check-in — 12 months, dose 3
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-29	Pfizer-BioNTech
2	2021-01-19	Pfizer-BioNTech
3	2021-09-29	Pfizer-BioNTech	No

Call center

5 call center cases

3 unsuccessful · 2 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-29

Systemic reaction (other): Light headedness, mild palpitations

Release 1 — days 1–6 daily, dose 1

2020-12-30

Systemic reaction (other): Light-headedness, palpitations

2020-12-31

Systemic reaction (other): Mottling neuropathy of the hands

2021-01-01

Systemic reaction (other): Mild neuropathy of hands 1-2hrs

2021-01-02

Systemic reaction (other): Mild,neuropathy 1-2 hrs, hands

Release 2 — day 0, dose 2

2021-01-19

Systemic reaction (other): 1-Neuropathy in the left face and lips, 2- light-headedness

Release 2 — days 1–6 daily, dose 2

2021-01-21

Systemic reaction (other): Neuropathy in the hands, moderate

2021-01-22

Systemic reaction (other): Neuropathy, fingers, mild

2021-01-23

Systemic reaction (other): Mild neuropathy, hands

2021-01-24

Systemic reaction (other): Moderate neuropathy, hands

2021-01-25

Systemic reaction (other): Neuropathy, hands mild.

Release 2 — day 7, dose 2

2021-01-26

Systemic reaction (other): Mild neuropathy, hands

Release 3 — day 14, dose 2

2021-02-02

Symptoms: Worsening of chronic fatigue. Recurrent migraine headache. Worsened joint pain.

Release 4 — day 21, dose 2

2021-02-11

Symptoms: Persistent neuropathy across hands/feet and left side of face.

Release 4 — day 28, dose 2

2021-02-16

Symptoms: Sore throat with exudate. Complete oss of taste and smell

Release 10 — day 14, dose 3

2021-10-14

Symptoms: Inflammatory arthritis flare

Release 10 — 3 months, dose 3

2021-12-29

Symptoms: Intractable headache X1 week

Release 11 — 6 months, dose 3

2022-03-31

Symptoms: Chronic Daily migraine persistent since on 12/28/21

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	✓	✓	✓
SD	Anosmia	✓	✓	✓
SD	Arthralgia	✓	✓	✓
SD	Arthritis	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	·	·	✓
SD	Migraine	✓	✓	✓
SD	Neuropathy peripheral	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Adverse reaction	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Livedo reticularis	✓	✓	✓
SRO	Neuropathy peripheral	✓	✓	✓
SRO	Palpitations	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release